Pfizer (PFE) and Merck (MRK) reported their second quarter earnings, with both companies beating expectations. Grey Ghost Advisors CEO Meghan Fitzgerald...
, with both companies beating expectations. Grey Ghost Advisors CEO Meghan Fitzgerald joins Catalysts to give insight into Pfizer and Merck 's recent earnings and what the reports signal about the broader healthcare sector .
Amid this A I driven market rally are the earnings that we've gotten in so far from some of these health care names bolstering that view in your opinion.One there's been a billion dollars in deals this year so far, the majority of big Pharma trade below the S and P five hundreds forward.So what we're seeing is investors wanna take risk, but they're expecting outside returns.
So I think, you know, we tend to just perform and you see the science, I think a lot of what's going on in tech has been a lot of investment, but we really haven't seen the Roy of that investment.And their story gave them a chance to highlight a strategy past COVID, which they deserve a lot of credit for.
So the core business rose 14% on an operating basis when you take out COVID and also the COVID franchise.So it's not like the COVID franchise has fallen away.Pfizer also said they're gonna do 20 billion in revenue on its own and 25 billion from their acquisitions. So I think we can't really underestimate the power of what this space could be and what the impact will be on public health and markets going forward.Princess Anne’s favourite sunglasses are now in style – and you can buy them for £20
Pfizer Merck Healthcare Sector
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck’s Keytruda rules in cancer to drive profit and salesMerck & Co. beat Wall Street’s profit and sales estimates for the quarter as the blockbuster immunotherapy Keytruda continued to dominate the market for cancer medicines.
Read more »
Merck second quarter tops Street view on strong Keytruda salesMerck & Co posted higher-than-expected second-quarter results on Tuesday on strong growth of its blockbuster cancer immunotherapy Keytruda, the world's best-...
Read more »
Pfizer moves forward with once-daily weight-loss pillShares of Pfizer (PFE) are rising slightly in early trading on Thursday after announcing it will be moving forward with a once-daily weight-loss pill...
Read more »
Pfizer plans to move forward with once-daily weight loss pillThe new drug is part of the second-generation of weight-loss pills under development by companies including Eli Lilly and Novo Nordisk that will offer patients a more convenient alternative to injections
Read more »
How one VC is investing in weight-loss drug marketPlenty of big pharma companies are betting on weight-loss drugs, including Pfizer (PFE), Novo Nordisk (NVO), and Eli Lilly (LLY). But there are plenty of...
Read more »
Canadian Forces Hercules plane spotted circling cityNo word on why the rescue aircraft is in the area
Read more »